Hunan Weitou Scientific Technology

Hunan Weitou Scientific Technology appears to be a Chinese corporate entity better characterized as an investment or holding company rather than a life science, biotech, pharma, or healthcare operating business. Publicly accessible references to the company are sparse, and the clearest mentions identify it in connection with a 2022 equity investment agreement with AnPac Bio rather than as a developer of therapeutics, diagnostics, or medical products. The available evidence does not show an internal drug pipeline, clinical programs, or a healthcare product portfolio. As a result, it should not be classified as a biotech or healthcare company based on currently verifiable public information.